Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2006

01-02-2006 | Original Paper

The Role of GPs in Increasing Compliance to Colorectal Cancer Screening: A Randomised Controlled Trial (Italy)

Authors: Antonio Federici, Paolo Giorgi Rossi, Francesco Bartolozzi, Sara Farchi, Piero Borgia, Gabriella Guastcchi

Published in: Cancer Causes & Control | Issue 1/2006

Login to get access

Abstract

Aims To assess the effect of the provider (GPs versus hospital) on the compliance in returning the faecal occult blood test. To analyse the characteristics of the GP associated with high compliance among his beneficiaries.
Methods A questionnaire about screening attitudes was mailed to the 1192 GPs working in 13 districts of the Lazio region. We asked the GPs to participate in a randomised trial, we sampled 130 GPs and about 1/10 of the GPs’ 50–75 year old beneficiaries (n = 3657) were invited to be screened at the GP office and 1/10 (3675) at the nearest gastroenterology centre.
Results 58.5% of the GPs completed the questionnaire and 22.7% agreed to participate in the trial. The compliance in the GP arm was 50%, in the hospital arm 16% (RR 3.4; 95% CI: 3.13–3.70). There was a high variability in the compliance obtained by the GPs. GPs with more than 25 patients visited/day and those incorrectly recommended screening of colorectal cancer obtained a lower compliance (OR 0.74, 95% CI: 0.57–0.95 and OR 0.76, 95% CI: 0.59–0.97, respectively).
Conclusions The involvement of GPs in colorectal cancer screening can be very effective to enhance the compliance, but the effectiveness is dependent on their willingness to be involved.
Literature
1.
European Union. Council Recommendation of 2 December 2003 on cancer screening. 2003/878/EC.
2.
Madlensky, L, Goel, V, Polzer, J, Ashbury, FD 2003Assessing the evidence for organised cancer screening programmesEur J Cancer3916481653PubMedCrossRef
3.
Towler, BP, Irwig, L, Glasziou, P, Weller, D, Kewenter, J 2000Screening for colorectal cancer using the faecal occult blood test, hemoccultCochrane Database Syst Rev2CD001216PubMed
4.
American Gastroenterological Association1997Colorectal cancer screening:clinical guidelines and rationaleGastroenterology112594642
5.
Pye, G, Christie, M, Chamberlain, JO, Moss, SM, Hardcastle, JD 1988A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workloadJ Epidemiol Community Health426671PubMed
6.
Jepson, R, Clegg, A, Forbes, C, Lewis, R, Sowden, A, Kleijnen, J 2000The determinants of screening uptake and interventions for increasing uptake:a systematic reviewHealth Technol Assess41133
7.
Klabunde, CN, Frame, PS, Meadow, A, Jones, E, Nadel, M, Vernon, SW 2003A national survey of pri-mary care physicians’ colorectal cancer screening recommendations and practicesPrev Med36352362PubMedCrossRef
8.
Hawley, ST, Levin, B, Vernon, SW 2001Colorectal cancer screening by primary care physicians in two medical care organizationsCancer Detect Prev25309318PubMed
9.
Sladden, MJ, Ward, JE 1999Australian general practitioners’ views and use of colorectal cancer screening testsMed J Aust170110113PubMed
10.
Schapira, DV, Pamies, RJ, Kumar, NB, Herold, AH, Durme, DJ, Woodward, LJ, Roetzheim, RG 1993Cancer screening. Knowledge, recommendations, and practices of physiciansCancer71839843PubMed
11.
Sharma, VK, Vasudeva, R, Howden, CW 2000Colorectal cancer screening and surveillance practices by primary care physicians:results of a national surveyAm J Gastroenterol9515511556PubMed
12.
Lemon, SC, Zapka, JG, Estabrook, B, Erban, S, Luckmann, R 2003Screening for colorectal cancer on the front lineAm J Gastroenterol98915923PubMedCrossRef
13.
Schattner, A, Gilad, A 2002Primary care physicians’ awareness and implementation of screening guidelines for colorectal cancerPrev Med35447452PubMedCrossRef
14.
Federici, A, Bartolozzi, F, Farchi, S, Borgia, P, Guasticchi, G 2005Survey on colorectal cancer screening knowledge, attitudes and practices of general practice physicians in Lazio, ItalyPrev Med413035PubMedCrossRef
15.
Cole, SR, Young, GP 2001Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancerMed J Aust17519519820PubMed
16.
Powe, BD 2002Promoting fecal occult blood testing in rural African American womenCancer Pract10139146PubMedCrossRef
17.
Friedman, LC, Everett, TE, Peterson, L, Ogbonnaya, KI, Mendizabal, V 2001Compliance with fecal occult blood test screening among low-income medical outpatients:a randomized controlled trial using a videotaped interventionJ Cancer Educ168588PubMed
18.
Ore, L, Hagoel, L, Lavi, I, Rennert, G 2001Screening with faecal occult blood test (FOBT) for colorectal cancer:assessment of two methods that attempt to improve complianceEur J Cancer Prev10251256PubMedCrossRef
19.
Fernandez, JL, Gallegos, M, Brochero, A, Arevalo, C, Piccioni, H, Gutierrez Galiana, H 1999[Screening for colorectal cancer with an immunochemical fecal occult blood test]Acta Gastroenterol Lati-noam297378
20.
Nichols, S, Koch, E, Lallemand, RC, Heald, RJ, Izzard, L, Machin, D, Mullee, MA 1986Randomised trial of compliance with screening for colorectal cancerBr Med J (Clin Res Ed)293107110
21.
Cole, SR, Young, GP, Esterman, A, Cadd, B, Morcom, J 2003A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancerJ Med Screen10117122PubMedCrossRef
22.
Cole, SR, Young, GP, Byrne, D, Guy, JR, Morcom, J 2002Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitionerJ Med Screen9147152PubMedCrossRef
23.
Vinker, S, Nakar, S, Rosenberg, E, Kitai, E 2002The role of family physicians in increasing annual fecal occult blood test screening coverage:a prospective intervention studyIsr Med Assoc J4424425PubMed
24.
Giorgi Rossi, P, Federici, A, Bartolozzi, F, Farchi, S, Borgia, P, Guastcchi, G 2005Trying to improve the compliance to colorectal cancer screening:a complex study design for a complex planning questionCont Clin Trial26323330
25.
Federici, A, Giorgi Rossi, P, Borgia, P, Bartolozzi, F, Farchi, S, Gausticchi, G 2005The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programs:a cluster randomised controlled trialJ Med Screen128388PubMedCrossRef
26.
27.
Stata 7.0, Statistics/Data Analysis. Stata Corporation, 4905 Lakeway Drive, College Station, Texas 77845, USA.
28.
Zhang, J, Yu, KF 1998What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomesJAMA28016901691PubMedCrossRef
29.
Hsieh FY (1997) Sample size formulae for intervention studies with the cluster as unit of randomization. Stat Med. 1988; 7:1195–1201. Erratum in:Stat Med 15;16:1300.
30.
Hart, AR, Barone, TL, Gay, SP, Inglis, A, Griffin, L, Tallon, CA, Mayberry, JF 1997The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central EnglandJ Epidemiol Community Health51187191PubMed
31.
Wardle, J, Williamson, S, McCaffery, K, Sutton, S, Taylor, T, Edwards, R, Atkin, W 2003Increasing at-tendance at colorectal cancer screening:testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adultsHealth Psychol2299105PubMed
32.
Grazzini, G, Castiglione, G, Ciabattoni, C, Franceschini, F, Giorgi, D, Gozzi, S, Mantellini, P, Lopane, P, Perco, M, Rubeca, T, Salvadori, P, Visioli, CB, Zappa, M 2004Colorectal cancer screening programme by faecal occult blood test in Tuscany:first round resultsEur J Cancer Prev131926PubMed
Metadata
Title
The Role of GPs in Increasing Compliance to Colorectal Cancer Screening: A Randomised Controlled Trial (Italy)
Authors
Antonio Federici
Paolo Giorgi Rossi
Francesco Bartolozzi
Sara Farchi
Piero Borgia
Gabriella Guastcchi
Publication date
01-02-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 1/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0380-9

Other articles of this Issue 1/2006

Cancer Causes & Control 1/2006 Go to the issue

Original Paper

Breast Cancer Screening among Low-Income or Uninsured Women: Results from the National Breast and Cervical Cancer Early Detection Pogram, July 1995 to March 2002 (United States)

Original Paper

Are Findings from Studies of Obesity and Prostate Cancer Really in Conflict?

Original Paper

Physical Activity and Risk of Ovarian Cancer: Results from the Netherlands Cohort Study (The Netherlands)

Original Paper

Breast Cancer and Night Work among Norwegian Nurses

Editorial

A Weight Loss Trial for Breast Cancer Recurrence: Pre-Menopausal, Post-Menopausal, Both, or Neither?

Original Paper

Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits